BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wong JS, Cheah YK. Potential miRNAs for miRNA-Based Therapeutics in Breast Cancer. Noncoding RNA 2020;6:E29. [PMID: 32668603 DOI: 10.3390/ncrna6030029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Viera M, Yip GWC, Shen HM, Baeg GH, Bay BH. Targeting CD82/KAI1 for Precision Therapeutics in Surmounting Metastatic Potential in Breast Cancer. Cancers (Basel) 2021;13:4486. [PMID: 34503296 DOI: 10.3390/cancers13174486] [Reference Citation Analysis]
2 Sheykhhasan M, Kalhor N, Sheikholeslami A, Dolati M, Amini E, Fazaeli H. Exosomes of Mesenchymal Stem Cells as a Proper Vehicle for Transfecting miR-145 into the Breast Cancer Cell Line and Its Effect on Metastasis. Biomed Res Int 2021;2021:5516078. [PMID: 34307654 DOI: 10.1155/2021/5516078] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Nirgude S, Desai S, Choudhary B. Curcumin alters distinct molecular pathways in breast cancer subtypes revealed by integrated miRNA/mRNA expression analysis. Cancer Rep (Hoboken) 2022;:e1596. [PMID: 34981672 DOI: 10.1002/cnr2.1596] [Reference Citation Analysis]